The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes.
Dong S, Hiam-Galvez KJ, Mowery CT, Herold KC, Gitelman SE, Esensten JH, Liu W, Lares AP, Leinbach AS, Lee M, Nguyen V, Tamaki SJ, Tamaki W, Tamaki CM, Mehdizadeh M, Putnam AL, Spitzer MH, Ye CJ, Tang Q, Bluestone JA.
Dong S, et al. Among authors: tamaki w, tamaki sj, tamaki cm.
JCI Insight. 2021 Sep 22;6(18):e147474. doi: 10.1172/jci.insight.147474.
JCI Insight. 2021.
PMID: 34324441
Free PMC article.
Clinical Trial.